Privacy Policy

Effective January 16, 2012

Pacira Pharmaceuticals, Inc.

Privacy Policy

This Privacy Policy applies to the websites located at pacira.com and EXPAREL.com (collectively, the “Sites”) that are operated by or behalf of Pacira Pharmaceuticals, Inc. or its affiliates (the “Company”). Our Privacy Policy is designed to tell you about the policies that govern our collection, use, and disclosure of the information collected in connection with our Sites. Please read this entire Privacy Policy prior to browsing our Sites or submitting any information to us. Use of the Sites constitutes your consent to the policies and practices described in this Privacy Policy.

Applicability
This Privacy Policy applies only to the Sites, and not to any other websites that may be linked or referred to from the Sites. We do not control such other websites, and this Privacy Policy does not apply to any such websites. Visitors to other websites are encouraged to read their privacy policies before exploring them. Please note that depodur.com is controlled by EKR Therapeutics and is therefore not a Site and is not governed by this Privacy Policy.

Collected Information
Information You Provide: Through interaction with the Sites, you may choose to provide to the Company what is generally called “personally identifiable” information, such as your name, e-mail address, physical mailing address, and telephone numbers, as well as non-personally identifiable information such as your zip code, gender or year of birth. For example, this may occur through your registering for use of certain portions of a Site, signing up for a mailing list, choosing to fill out and submit a form on a Site that requests such information, or your sending the Company an e-mail to an address you find on a Site. Please note that we will only collect personally identifiable information from you in the event you choose to provide it to us.

Automatically Collected Information: Certain non-personally identifiable information is collected automatically when you browse the Sites, such as your IP address, the referring URL, web browser version, and date and time. We do not collect any personally identifiable information automatically.

Cookies and Beacons: When you visit the Sites, our servers may send one or more “cookies” to your computer system. A “cookie” is a small text file containing a string of alphanumeric characters. We may use “persistent cookies,” which stay on your system after you are done visiting the Sites, as well as “session cookies,” which remain on your system only while you remain on the Sites. Cookies may be used in connection with “beacons,” which are usually 1x1 pixel clear images that allow for cookies to be placed and read and for web page views to be counted. No personally identifiable information is collected or stored through cookies.

Use and Disclosure of Information
Use of Information: Your name, address, e-mail address, and any other personally identifiable information you provide may be used by the Company to provide you with information you request and in connection with marketing activities relating to Company products and services. We may combine personally identifiable information with other actively collected information unless we specify otherwise at the point of collection. The Company endeavors to comply with CAN-SPAM and other applicable advertising laws, and will provide unsubscribe information in any commercial e-mail messages that we may send to you.

Opting Out of Communications: The Company endeavors to comply with CAN-SPAM and other applicable advertising laws, and will provide unsubscribe information in any commercial e-mail messages that we may send to you. Alternatively, you may also unsubscribe from any commercial e-mail messages or marketing communications by sending an e-mail directly to Opt-Out@pacira.com. Please include `unsubscribe' in your subject line and the e-mail address or contact information you wish excluded from marketing communications.

Non-personally identifiable information, including cookies information, may be used by the Company to improve our Sites, products and services; to conduct marketing and advertising activities; to understand usage trends and preferences to remember your web browser so you do not need to re-enter your information the next time you visit a Site; to provide customized content; or to measure and track your usage of the Sites. If we send you e-mail, such e-mail may contain a pixel that allows us to measure whether the e-mail was viewed or clicked on.

Disclosure of Information: We may provide information to third parties to assist us in our marketing efforts, to improve the Sites, to provide web hosting, maintenance and security services to the Company, or to assist us with the other uses described in this Privacy Policy. In such cases, we will do so pursuant to agreements that require such third parties to use the information only on the Company’s behalf in accordance with this Privacy Policy. Will do not sell or rent personally identifiable information collected in connection with the Sites.

We reserve the right to disclose any information to respond to requests from governmental authorities or where the Company has a good faith belief that such disclosure is required by law or legal process, such as a subpoena. In addition, we reserve the right to use or disclose information to the extent reasonably necessary to defend the Company from claims or allegations or to protect the rights, safety or property of the Company or any third party.

Third Party Advertising Service Providers
We may work with third party advertising services providers who may use their own cookies to measure how many times advertising content has been viewed and to serve you advertising that may be more relevant to you. For more information on such practices and an opportunity to opt-out of them, please visit http://www.aboutads.info.

Merger or Sale of Company
In the event that Company is acquired by or merged with a third-party entity, we reserve the right, in any of these circumstances, to transfer or assign the information that we have collected from Users as part of that merger or acquisition.

International Users
If you are visiting the Sites from the European Union or other non-U.S. territories, please note that any data you provide will be transferred outside the European Union or such other non-U.S. territory for use by Company for any of the purposes described herein. By providing any data to the Company, you hereby consent to such transfers of your data to the United States.

Security
The Company uses commercially reasonable physical and technical safeguards to preserve the integrity and security of your personal information. We cannot, however, ensure or warrant the security of any information you transmit to Company, and you do so at your own risk. E-mail communications in particular are not secure. Once we receive your transmission of information, Company makes commercially reasonable efforts to ensure the security of our systems. However, please note that this is not a guarantee that such information may not be accessed, disclosed, altered, or destroyed by breach of any of our safeguards.

Protection of Children
The Company will not knowingly collect, use or disclose personally identifiable information from a minor under the age of 13, without obtaining prior consent from a person with parental responsibility (parent or guardian). If you are under the age of 13, please do not use the Sites or submit any information in connection with the Site.

How to Contact Us
If you have any questions, comments, or concerns about this Privacy Policy or the information collection practices of this site, please contact us at:

Pacira Pharmaceuticals, Inc.
Attn: General Counsel
5 Sylvan Way
Parsippany, NJ 07054

Changes to This Privacy Policy
Pacira Pharmaceuticals, Inc. reserves the right to modify, add or remove portions of this privacy policy at its discretion. Any changes to this Privacy Policy will be posted on this site. Please check back periodically, and especially before you provide any personally identifiable information.

Other Terms
Your use of the Sites is subject to our Legal Notice.

Important Notice

This site is for informational purposes only and is intended to address medical questions from healthcare professionals in the United States.

To report an adverse event, e-mail drugsafety@pacira.com or dial 1-855-RX-EXPAREL (1-855-793-9727).

For medical inquiries related to EXPAREL, submit a request to Medical Information or call 1-855-RX-EXPAREL (1-855-793-9727).

These are not all of the potential important safety considerations for EXPAREL; please see the full Prescribing Information.

Important Safety Information

Warnings and Precautions Specific to EXPAREL

Warnings and Precautions for Bupivacaine-Containing Products

Please refer to full Prescribing Information.

Important Safety Information

Medical Information

US healthcare professionals Click Here

Non-US healthcare professionals can submit a request to medinfo@pacira.com

If you are not a healthcare professional, please discuss any questions you have regarding your health or treatment with your physician, pharmacist, nurse, or other healthcare professional.

Important information about EXPAREL®

The FDA confirms that EXPAREL has always been approved for "administration into the surgical site to produce postsurgical analgesia" for use in a variety of surgeries not limited to those studied in its pivotal trials.

"We are pleased to announce a successful collaboration with the FDA to resolve this matter in an expeditious and meaningful way that allows us to get back to the important task at hand—reducing postsurgical opioid exposure by providing a non-opioid option like EXPAREL to as many patients as appropriate."

- Dave Stack, Chief Executive Officer and Chairman of Pacira

The clinical benefit of the decrease in opioid consumption was not demonstrated in the pivotal trials.

Important Safety Information

  • EXPAREL is contraindicated in obstetrical paracervical block anesthesia
  • In clinical trials, the most common adverse reactions (incidence ≥10%) following EXPAREL administration were nausea, constipation, and vomiting
  • EXPAREL is not recommended to be used in the following patient population: patients <18 years old and/or pregnant patients
  • Because amide-type local anesthetics, such as bupivacaine, are metabolized by the liver, EXPAREL should be used cautiously in patients with hepatic disease. Patients with severe hepatic disease, because of their inability to metabolize local anesthetics normally, are at a greater risk of developing toxic plasma concentrations

Warnings and Precautions Specific to EXPAREL

  • EXPAREL is not recommended for the following types or routes of administration: epidural, intrathecal, regional nerve blocks, or intravascular or intra-articular use
  • Non-bupivacaine-based local anesthetics, including lidocaine, may cause an immediate release of bupivacaine from EXPAREL if administered together locally. The administration of EXPAREL may follow the administration of lidocaine after a delay of 20 minutes or more. Formulations of bupivacaine other than EXPAREL should not be administered within 96 hours following administration of EXPAREL

Warnings and Precautions for Bupivacaine-Containing Products

  • Central Nervous System (CNS) Reactions: There have been reports of adverse neurologic reactions with the use of local anesthetics. These include persistent anesthesia and paresthesias. CNS reactions are characterized by excitation and/or depression
  • Cardiovascular System Reactions: Toxic blood concentrations depress cardiac conductivity and excitability which may lead to dysrhythmias sometimes leading to death
  • Allergic Reactions: Allergic-type reactions (eg, anaphylaxis and angioedema) are rare and may occur as a result of hypersensitivity to the local anesthetic or to other formulation ingredients
  • Chondrolysis: There have been reports of chondrolysis (mostly in the shoulder joint) following intra-articular infusion of local anesthetics, which is an unapproved use

Please refer to full Prescribing Information.

PATIENTS

Click Here >

to continue to the Patient site.

DOCTORS

Click Here >

to continue to the HCP site.

EXPAREL® (bupivacaine liposome injectable suspension) Sign Up

Sign up to receive updates on EXPAREL.

 
Providing the optional information about you below enables us to provide information geared to your needs.
Yes, I would like to receive periodic updates about EXPAREL via e-mail. I agree to the Privacy Policy
 

Thank you! Your registration is complete.

Sorry. There was an error submitting your request. Please try again at another time.

Sorry. The connection to the server was lost. Please try again at another time.